Filing Details
- Accession Number:
- 0001209191-19-058382
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-27 19:34:12
- Reporting Period:
- 2019-11-26
- Accepted Time:
- 2019-11-27 19:34:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1423084 | J. Thomas Schall | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-26 | 279,166 | $6.30 | 2,508,021 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-26 | 21,641 | $27.30 | 2,486,380 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 14,134 | $28.44 | 2,472,246 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 31,335 | $29.23 | 2,440,911 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 78,581 | $30.79 | 2,362,330 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 32,780 | $31.76 | 2,329,550 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 14,969 | $32.65 | 2,314,581 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 29,290 | $33.86 | 2,285,291 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 54,936 | $34.69 | 2,230,355 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 1,500 | $35.60 | 2,228,855 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2019-11-26 | 279,166 | $0.00 | 279,166 | $6.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-08-11 | 2020-08-11 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a March 2019 Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $26.90 to $27.89 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $27.90 to $28.80 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $28.94 to $29.85 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $30.17 to $31.16 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $31.17 to $32.15 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $32.17 to $33.15 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $33.18 to $34.17 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $34.18 to $35.10 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $35.18 to $36.14 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- As of November 26, 2019, and prior to this transaction, the exercised options were fully vested.
- Not applicable.
Billionaire Hedge Funds
